Sun Pharma starts Phase II trial of SCD-044 for moderate to severe plaque psoriasis
SCD-044 is also being evaluated in other autoimmune disorders and Phase 2 studies for other indications like atopic dermatitis,…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
SCD-044
SPARC and Sun Pharma enter into license agreement for SCD-044
It is a potential treatment for atopic dermatitis, psoriasis and other auto-immune disorders